share_log

DA32 Life Science Tech Acquisition (NASDAQ:DALS) Trading 0.3% Higher

DA32 Life Science Tech Acquisition (NASDAQ:DALS) Trading 0.3% Higher

DA32生命科学技术收购(纳斯达克:DALS)上涨0.3%
Financial News Live ·  2022/10/28 15:51

DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS – Get Rating) shares traded up 0.3% during trading on Wednesday . The company traded as high as $9.80 and last traded at $9.80. 20,429 shares traded hands during trading, a decline of 75% from the average session volume of 82,249 shares. The stock had previously closed at $9.77.

DA32生命科学技术收购公司(纳斯达克代码:DALS-GET Rating)的股票周三在交易中上涨0.3%。该公司股价一度高达9.80美元,最新报9.80美元。当日有20,429股股票成交,较82,249股的平均成交量下降75%。该股此前收盘价为9.77美元。

DA32 Life Science Tech Acquisition Stock Performance

DA32生命科学技术收购股票表现

The stock has a 50 day moving average of $9.74 and a 200 day moving average of $9.72.

该股的50日移动均线切入位为9.74美元,200日移动均线切入位为9.72美元。

Get
到达
DA32 Life Science Tech Acquisition
DA32生命科学技术收购
alerts:
警报:

Institutional Inflows and Outflows

机构资金流入和流出

Institutional investors and hedge funds have recently modified their holdings of the business. Spartan Fund Management Inc. bought a new position in shares of DA32 Life Science Tech Acquisition in the first quarter worth $181,000. Ursa Fund Management LLC bought a new position in shares of DA32 Life Science Tech Acquisition in the first quarter worth $243,000. Piper Sandler & CO. acquired a new stake in shares of DA32 Life Science Tech Acquisition in the first quarter valued at $244,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new stake in shares of DA32 Life Science Tech Acquisition in the first quarter valued at $486,000. Finally, Fir Tree Capital Management LP acquired a new stake in shares of DA32 Life Science Tech Acquisition in the first quarter valued at $758,000. Institutional investors own 60.43% of the company's stock.

机构投资者和对冲基金最近调整了对该公司的持股。斯巴达基金管理公司在第一季度购买了价值181,000美元的DA32生命科学技术收购的新股票头寸。Ursa Fund Management LLC在第一季度购买了DA32 Life Science Tech收购的新股票头寸,价值24.3万美元。派珀·桑德勒公司在第一季度收购了DA32生命科学技术收购的新股份,价值244,000美元。宾夕法尼亚州联邦公立学校Empls Retrmt Systems在第一季度收购了DA32生命科学技术公司的新股份,价值486,000美元。最后,Fir Tree Capital Management LP在第一季度收购了DA32生命科学技术收购公司的新股份,价值75.8万美元。机构投资者持有该公司60.43%的股份。

DA32 Life Science Tech Acquisition Company Profile

DA32生命科学技术收购公司简介

(Get Rating)
(获取评级)

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors.

DA32生命科学技术收购公司没有重大业务。它侧重于与一个或多个企业进行合并、资本换股、资产收购、股票购买、重组或相关业务合并。该公司打算确定生物技术和生命科学基础设施领域的业务合并目标。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on DA32 Life Science Tech Acquisition (DALS)
  • McDonald's Stock Sizzles, but Will it Hit a New All-Time High?
  • Why is Amazon Stock Falling? Is the Sell-Off Overdone?
  • Will Ryanair Stock Gains, Strong Estimates Help it Fly?
  • Can Comcast Monetize Existing Users for Streaming Success?
  • Apple Inc. Stock Q4 Results Beat Negative Outlook, Stock Rises
  • 免费获取StockNews.com关于DA32生命科学技术收购(DALS)的研究报告
  • 麦当劳股价下跌,但它会创下历史新高吗?
  • 为什么亚马逊的股票会下跌?抛售是否过头了?
  • 瑞安航空股价上涨,强劲的预期是否会帮助它飞起来?
  • 康卡斯特能否通过流媒体的成功将现有用户货币化?
  • 苹果。第四季度业绩好于负面预期,股价上涨

Receive News & Ratings for DA32 Life Science Tech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DA32 Life Science Tech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

获得DA32生命科学技术收购日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对DA32生命科学技术收购和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发